Effects of Fibrillar C–Terminal Fragment of Cleaved α1–Antitrypsin on Cholesterol Homeostasis in Hepg2 Cells
Open Access
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 29 (2) , 434-442
- https://doi.org/10.1002/hep.510290217
Abstract
Amyloid fibrils of diverse origin are known to disturb vital cellular functions and induce cell death. In this study, the effects of amyloid fibrils from the C–terminal fragment (C–36) of cleaved α1 –antitrypsin (AAT) on low–density lipoprotein (LDL) metabolism were investigated in HepG2 cells. Treatment of the cells with C–36 fibrils (10 μmol/L) enhanced 125I–LDL binding and uptake 10 to 15 times, and highly up–regulated levels of LDL receptor mRNA, as compared with control cells. Competition experiments using excess of unlabeled LDL and blockage experiments with a monoclonal LDL receptor antibody diminished or completely abolished the stimulatory effects of fibrils on LDL binding and LDL receptor mRNA levels, suggesting that fibrils act via the LDL receptor pathway. However, C–36 fibrils had no significant effect on [2–14C]acetate incorporation into cholesterol biosynthesis and cholesterol ester formation, but inhibited125I–LDL degradation by 20% and reduced bile acid biosynthesis up to 48% in a dose–dependent manner. Preincubation of the cells with fibrils before the addition of LDL totally abolished the LDL inhibitory effect on unesterified cholesterol synthesis, further confirming the LDL receptors to be the target for C–36 fibrils. Moreover, the expression of sterol regulatory element binding protein–1 (SREBP–1) was found to increase twofold and more after 24 hours of incubation of the cells with several concentrations of C–36 fibrils. Our study suggests that the cytotoxicity of C–36 fibrils on HepG2 cells is associated with perturbed intracellular cholesterol homeostasis, induced through fibril–stimulated expression of the LDL receptors via the sterol–responsive elementKeywords
This publication has 48 references indexed in Scilit:
- Binding of urokinase-type plasminogen activator–plasminogen activator inhibitor-1 complex to the endocytosis receptors α2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitorBiochemical Journal, 1998
- Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsinScandinavian Journal of Clinical and Laboratory Investigation, 1997
- Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and α1-Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related ProteinPublished by Elsevier ,1996
- ReviewBiological Chemistry Hoppe-Seyler, 1996
- Proteolytic inactivation of human α1 antitrypsin by human stromelysinFEBS Letters, 1991
- Human neutrophil collagenase cleaves α1-antitrypsinBiochemical Journal, 1990
- Elastase-α1antitrypsin complexes in acute leukaemiaThrombosis Research, 1985
- Purification of Human Plasma α1-Proteinase Inhibitor and Its Inactivation by Pseudomonas aeruginosa ElastaseThe Journal of Biochemistry, 1984
- HUMAN PLASMA PROTEINASE INHIBITORSAnnual Review of Biochemistry, 1983
- Inactivation of human plasma α1-proteinase inhibitor by a metalloproteinase from serratia marcescensBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982